Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
John DiPersio, MD, PhD, Washington University School of Medicine, Saint Louis, MO, highlights the key updates in CAR T-cell therapy from the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL. Dr DiPersio specifically discusses new CAR-T therapies, and the combination of CAR-T therapy with gene editing platforms.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.